ANAPTYSBIO, INC. (ANAB) Net margin 2016–2025
ANAPTYSBIO, INC. (ANAB) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.6%FY2025 · since FY2016: -25.5% → -5.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.6% | +153.5 pp |
| FY2024 | -159.1% | +794.6 pp |
| FY2023 | -953.7% | +297.7 pp |
| FY2022 | -1251.3% | -1159.8 pp |
| FY2021 | -91.5% | -64.9 pp |
| FY2020 | -26.6% | +1190.1 pp |
| FY2019 | -1216.7% | +16.4 pp |
| FY2018 | -1233.1% | -932.4 pp |
| FY2017 | -300.7% | -275.2 pp |
| FY2016 | -25.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice